Cargando…
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
BACKGROUND: Chemotherapy for soft tissue sarcomas remains unsatisfactory due to their low chemosensitivity. Even the first line chemotherapeutic agent doxorubicin only yields a response rate of 18-29%. The antibiotic salinomycin, a potassium ionophore, has recently been shown to be a potent compound...
Autores principales: | Liffers, Sven-T, Tilkorn, Daniel J, Stricker, Ingo, Junge, Christoph Günter, Al-Benna, Sammy, Vogt, Markus, Verdoodt, Berlinda, Steinau, Hans-U, Tannapfel, Andrea, Tischoff, Iris, Mirmohammadsadegh, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854645/ https://www.ncbi.nlm.nih.gov/pubmed/24144362 http://dx.doi.org/10.1186/1471-2407-13-490 |
Ejemplares similares
-
Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
por: Verdoodt, Berlinda, et al.
Publicado: (2012) -
Biphasic Synovial Sarcoma of the Extremity: Quadruple Approach of Isolated Limb Perfusion, Surgical Ablation, Adipofascial Perforator Flap and Radiation to Avoid Amputation
por: Steinstraesser, Lars, et al.
Publicado: (2011) -
Suppression of Soft Tissue Sarcoma Growth by a Host Defense-Like Lytic Peptide
por: Steinstraesser, Lars, et al.
Publicado: (2011) -
The Vascularised Groin Chamber: A Novel Model for Growing Primary Human Liposarcoma in Nude Mice
por: Tilkorn, Daniel Johannes, et al.
Publicado: (2012) -
Feasibility of chemosensitivity testing in soft tissue sarcomas
por: Lehnhardt, Marcus, et al.
Publicado: (2005)